The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women
Open accessAbstract
BACKGROUND: Women infected with human immunodeficiency virus (HIV) are disproportionately affected by human papillomavirus (HPV)-related anogenital disease, particularly with increased immunosuppression. AIDS Clinical Trials Group protocol A5240 was a trial of 319 HIV-infected women in the United States, Brazil, and South Africa to determine immunogenicity and safety of the quadrivalent HPV vaccine in 3 strata based on screening CD4 count: >350 (stratum A), 201-350 (stratum B), and ≤200 cells/µL (stratum C). METHODS: Safety and serostatus of HPV types 6, 11, 16, and 18 were examined. HPV serological testing was performed using competitive Luminex immunoassay (HPV-4 cLIA). HPV type-specific seroconversion analysis was done for participants who were seronegative for the given type at baseline. RESULTS: Median age of patients was 36 years; 11% were white, 56% black, and 31% Hispanic. Median CD4 count was 310 cells/µL, and 40% had undetectable HIV-1 load. No safety issues were identified. Seroconversion proportions among women at week 28 for HPV types 6, 11,16, and 18 were 96%, 98%, 99%, and 91%, respectively, for stratum A; 100%, 98%, 98%, and 85%, respectively, for stratum B, and 84%, 92%, 93%, and 75%, respectively, for stratum C. CONCLUSIONS: The quadrivalent HPV vaccine targeted at types 6, 11, 16, and 18 was safe and immunogenic in HIV-infected women aged 13-45 years. Women with HIV RNA load >10 000 copies/mL and/or CD4 count <200 cells/µL had lower rates of seroconversion rates. Clinical Trials Registration. NCT00604175.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Cited by
Estimates of the global burden of cervical cancer associated with HIV
Stelzle, D., Tanaka, L. F., Lee, K. K., Ibrahim Khalil, A., Baussano, I., Shah, A. S. V., McAllister, D. A., Gottlieb, S. L., Klug, S. J., Winkler, A. S., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30459-9 · Cited by 925
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D'Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2768 · Cited by 328
Thompson, M. A., Horberg, M. A., Agwu, A. L., Colasanti, J. A., Jain, M. K., Short, W. R., Singh, T., & Aberg, J. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1391 · Cited by 256
Self-citationLooker, K. J., Rönn, M. M., Brock, P. M., Brisson, M., Drolet, M., Mayaud, P., & Boily, M. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25110 · Cited by 185
Canfell, K., Kim, J. J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J. A., Campos, N., Jennett, C., Sharma, M., Simms, K. T., et al. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.100184 · Cited by 68
Metadata
- Authors
- Kojic, E. M., Kang, M., Cespedes, M. S., Umbleja, T., Godfrey, C., Allen, R. T., Firnhaber, C., Grinsztejn, B., Palefsky, J. M., Webster-Cyriaque, J. Y., Saah, A., Aberg, J. A., & Cu-Uvin, S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-09
- Volume
- 59
- Issue
- 1
- Pages
- 127-135
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108018524
- Cited by
- 159
- References
- 1
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women. https://app.cochat.ai/papers/10.1093/cid/ciu238
- The paper
- Kojic, E. M., Kang, M., Cespedes, M. S., Umbleja, T., Godfrey, C., Allen, R. T., Firnhaber, C., Grinsztejn, B., Palefsky, J. M., Webster-Cyriaque, J. Y., Saah, A., Aberg, J. A., & Cu-Uvin, S. (2014). Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu238
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.